Breaking News

Financial Report: WuXi PharmaTech

Manufacturing revenues jump 149%

WuXi PharmaTech 2Q11

2Q Revenues: $101.1 million  (+25%)

2Q Earnings: $18.7 million (+36%)

YTD Revenues: $194.7 million (+20%)

YTD Earnings: $36.9 million (+26%)

Comments: Growth in the quarter was driven by Manufacturing Services revenue, up 149% to $21.0 million and China-based Laboratory Services, up 15% to $60.3 million. Laboratory Services were up 10% to $80.1 million in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters